Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122561) titled 'The Efficacy of farecimab in the treatment of diabetic macular edema' on April 15.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Bejing Tongren Hospital, Capital Medical Uniersity
Condition:
Diabetic Macular Edema
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-08-25
Target Sample Size: Patients receive faricimab treatment:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=270837
Published by HT Digital Content Services with permission from Health Daily Digest....